| Dermapharm Holding SE expands capacity to produce COVID-19 vaccine and plans for vaccine manufacturing to contribute high double-digit million € in sales in 2021

Corporate news to the archive Dermapharm Holding SE expands capacity to produce COVID-19 vaccine and plans for vaccine manufacturing to contribute high double-digit million € in sales in 2021 Grünwald, February 12, 2021 – Dermapharm Holding SE...

| Dermapharm Holding SE signs cooperation and delivery agreement with BioNTech SE on the production of a COVID-19 vaccine

Corporate news to the archive Dermapharm Holding SE signs cooperation and delivery agreement with BioNTech SE on the production of a COVID-19 vaccine Grünwald, September 10, 2020 – Dermapharm Holding SE (“Dermapharm”), a leading manufacturer of patent-free branded...
Michael Diegelmann

Newsletter subscription

Contact

+49 611 205 855 0

(Mon. - Fri. 09.00 - 18.00)

Answer Mon. - Fri.

within 24 hours

Newsletter subscription

Including a free extract of our bestseller book

Michael Diegelmann
Henryk_Deter

Newsletter subscription

Contact

+49 611 205 855 0

(Mon. – Fri. 09.00 – 18.00)

Answer Mon. – Fri.

within 24 hours

Newsletter subscription

Including a free extract of our bestseller book